CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CPIX on Nasdaq
Type / Class
Equity / Common Stock, no par value
Shares outstanding
15M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
3.41M
Holdings value
$10.6M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
30
Number of buys
9
Number of sells
-15
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KAZIMI A J 40.8% $27.7M 5.7M A.J. Kazimi 13 Feb 2025
Ikarian Capital, LLC 4.9% $3.55M 731K Ikarian Capital, LLC 31 Mar 2025
INTEGRATED CORE STRATEGIES (US) LLC 4% -30% $1.62M -$571K 599K -26.1% Integrated Core Strategies (US) LLC 30 Sep 2025

Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 3.41M $10.6M -$866K $3.12 30
2025 Q2 3.68M $12.3M -$2.45M $3.35 30
2025 Q1 4.28M $18.1M +$10.4M $4.23 33
2024 Q4 1.84M $4.36M -$464K $2.37 20
2024 Q3 2.04M $2.61M -$42.9K $1.28 22
2024 Q2 2.08M $3.18M -$134K $1.53 22
2024 Q1 2.16M $3.63M -$59.4K $1.68 22
2023 Q4 2.2M $3.89M -$17.6K $1.79 23
2023 Q3 2.21M $4.17M -$311K $1.89 20
2023 Q2 2.4M $3.52M -$75.7K $1.47 21
2023 Q1 2.45M $4.77M -$93K $1.95 21
2022 Q4 2.49M $5.61M +$78.5K $2.25 22
2022 Q3 2.45M $5.89M -$556K $2.41 15
2022 Q2 2.71M $5.62M -$447K $2.08 20
2022 Q1 2.9M $8.17M -$99.6K $2.82 24
2021 Q4 2.84M $13.2M +$376K $4.67 23
2021 Q3 2.77M $7.43M -$468K $2.68 20
2021 Q2 2.94M $8.36M -$813K $2.84 24
2021 Q1 3.22M $9.77M -$1.95M $3.03 27
2020 Q4 3.88M $11.4M -$522K $2.95 24
2020 Q3 4.03M $12.9M -$361K $3.21 22
2020 Q2 4.14M $13.8M -$1.83M $3.33 23
2020 Q1 4.67M $17M +$754K $3.63 21
2019 Q4 4.46M $23M -$197K $5.15 23
2019 Q3 4.48M $26.6M -$1.73M $5.93 26
2019 Q2 4.77M $30.4M -$985K $6.37 22
2019 Q1 4.92M $28.6M -$353K $5.81 22
2018 Q4 4.98M $30.5M -$2.11M $6.03 22
2018 Q3 5.36M $30.6M -$33.8K $5.71 30
2018 Q2 5.37M $32.9M -$466K $6.13 29
2018 Q1 5.43M $36.2M -$49.5K $6.68 29
2017 Q4 5.43M $40.1M +$84.3K $7.36 31
2017 Q3 5.42M $38.3M -$194K $7.06 30
2017 Q2 5.45M $38.3M -$395K $7.00 33
2017 Q1 5.51M $38.2M +$3.12M $6.94 34
2016 Q4 5.48M $30.1M +$360K $5.50 37
2016 Q3 5.42M $27.1M +$893K $5.00 38
2016 Q2 5.24M $23.6M +$115K $4.50 41
2016 Q1 5.22M $23.4M -$94.1K $4.49 46
2015 Q4 5.13M $27M -$442K $5.26 44
2015 Q3 5.21M $30.1M +$44.8K $5.77 44
2015 Q2 5.2M $37.2M -$1.83M $7.15 44
2015 Q1 5.47M $36.4M -$1.52M $6.66 42
2014 Q4 5.72M $34.2M -$3.79M $5.98 42
2014 Q3 6.36M $31.4M -$1.43M $4.94 44
2014 Q2 6.67M $30M -$216K $4.50 44
2014 Q1 6.72M $30.2M +$107K $4.50 46